An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief reviewPrasad Sanjay Dhiwar, Ganesh S. Andhale, Sindhuja Sengupta et al.|Journal of Biomolecular Structure and Dynamics|2023Cited by 28
Current updates on EGFR and HER2 tyrosine kinase inhibitors for the breast cancerPrasad Sanjay Dhiwar, Pujan Sasmal, Gurubasavaraja Swamy Purawarga Matada et al.|Medicinal Chemistry Research|2022Cited by 8
Design and Synthesis of Tri-substituted Imidazole Derivatives as CD73 Inhibitors for Their Anticancer ActivityAbhishek Ghara, Prasad Sanjay Dhiwar, Gurubasavaraja Swamy Purawarga Matada et al.|Letters in Drug Design & Discovery|2021Cited by 1